Labcorp OnDemandvsmyLAB Box
Labcorp OnDemand
myLAB Box
Side-by-side
| # | Product | Active ingredient | Starting price | FDA status | Score | Actions |
|---|---|---|---|---|---|---|
| 1 | Labcorp OnDemand | — | Best ·$29/mo | service | Top ·7.8 | See offer → |
| 2 | myLAB Box | — | $79/mo | service | 7.4 | See offer → |
Side-by-side scoring breakdown
How they work
Labcorp OnDemand is a testing service, not a therapy. After you purchase online, an independent provider network issues the required order. You then provide a sample, either at a Labcorp patient service center (blood, urine) or via a mail-in self-collection kit such as the ColoFIT stool test. Labcorp's CLIA-certified, CAP-accredited laboratories run standard clinical assays and post quantitative results to your secure portal.
You order a kit online, collect your own sample at home (finger-prick blood, urine, saliva, or an oral/vaginal/rectal swab depending on the test), and mail it back in a prepaid, discreet envelope. Samples are processed at high-complexity CLIA-certified and CAP-accredited laboratories, the same type that handle clinic specimens, using established methods such as nucleic acid amplification testing (NAAT/PCR) for STIs. Results post to a secure online dashboard, and a positive STI result unlocks a free telemedicine consult with a physician licensed in your state who can discuss treatment and may prescribe medication to a local pharmacy.
Effectiveness
Because testing is performed in Labcorp's own CAP-accredited, CLIA-certified laboratories using the same automated platforms and assays used in routine clinical care, analytical accuracy is on par with what a physician's order would yield; reviewers consistently rate the lab work itself as gold-standard. The ColoFIT mail-in kit is a fecal immunochemical test that detects occult blood as an early colorectal-cancer signal and is a screening tool, not a diagnostic replacement for colonoscopy.
myLAB Box does not run its own clinical trials; its credibility rests on the validated methods its partner labs use. The CDC identifies NAAT as the most sensitive and specific method for chlamydia and gonorrhea, noting FDA-cleared assays generally offer sensitivity well above 90% with very high specificity (usually 99% or higher). A 2015 systematic review and meta-analysis (PMC4500554) found self-collected vaginal swabs had about 92% sensitivity and 98% specificity versus clinician-collected cervical swabs, supporting self-collection as an acceptable approach. Note that the individual kits themselves are not FDA-approved; the company states its tests are laboratory-developed, its labs are CLIA-certified and CAP-accredited, and some test components are FDA-cleared.
Side effects
As a lab service there is no drug exposure. Physical risks are limited to routine venipuncture effects (bruising, soreness, rare fainting) for in-center draws and negligible risk for mail-in self-collection. The main non-physical risk is misreading an abnormal result without clinical context, which is why provider review and follow-up with your own doctor matter. Individual results vary.
As a testing service, there are no drug-style side effects. Physical risks are limited to minor finger-prick discomfort, a small bruise, or mild irritation from swabbing. The more meaningful risks are informational: a false negative (for example, testing inside an infection's window period) can give false reassurance, and a false positive can cause anxiety until confirmed. Self-collection errors or sample degradation in transit can also affect reliability, which is why any positive or concerning result should be confirmed with a clinician.
Cost & value
As of 2026, entry tests start near $49 and the ColoFIT mail-in kit is $89, with an independent-provider physician service fee folded into the listed price. Many tests are FSA/HSA eligible. Note that several headline-low prices apply to in-center draws rather than mail-in kits, so factor in a trip to a Labcorp location. No insurance billing; pay out of pocket.
As of 2026, expect to pay fully out of pocket. Individual tests run roughly $22 to about $99, while panels are priced higher: Safe Box (5-panel STI) around $179, Uber Box (8-panel) around $199, Total Box (14-panel) around $369, Thyroid screening around $125, and Women's Health + Fertility around $249. Insurance is not accepted, but FSA/HSA cards typically are, and the company frequently runs promo codes (often 10-20% off). Shipping is free both ways. Prices vary by promotion and resellers may list different figures, so confirm the current price at checkout.
Who it's for
Available to US adults purchasing their own tests; the independent provider network reviews each order for appropriateness. Some tests have age or location restrictions, and certain conditions (for example active GI bleeding for ColoFIT) make a given test unsuitable. Not a substitute for diagnostic care directed by your own physician.
Good for adults (and, per the company, those 14 and older) who want private, convenient screening, have a potential exposure, want routine sexual-health checks, or cannot easily access a clinic. Do not rely on it alone if you have acute or severe symptoms (e.g., pelvic pain, testicular pain, fever, or sores), are pregnant, or are managing a known condition; those situations need prompt in-person care. It does not test for HSV-1 (oral herpes), is not a diagnosis, and should not replace regular care with a clinician. Anyone with a positive or unexpected result should follow up with a provider for confirmation and treatment.
Bottom line
myLAB Box: myLAB Box is a legitimate at-home, mail-in testing service that ships your self-collected samples to CLIA-certified, CAP-accredited labs using clinic-grade methods like NAAT for STIs. It is convenient and discreet, with a free telehealth consult for positive STI results, but the kits themselves are not FDA-approved, results can take a week or more, insurance is not accepted, and it is a screening tool, not a substitute for a doctor. On balance, Labcorp OnDemand edges ahead in our scoring, but the right choice depends on your situation.
Sources behind our Labcorp OnDemand and myLAB Box reviews
- Labcorp OnDemand official site (order lab tests from home) — Labcorp
- ColoFIT Home Collection Test product page — Labcorp OnDemand
- FSA & HSA Eligible Lab Tests — Labcorp OnDemand
- About Labcorp OnDemand — Labcorp
- A Complete Review of LabCorp Medical Testing Services — Healthline (2024)
- Recommendations for Colorectal Cancer Screening (FIT) — Centers for Disease Control and Prevention
- Sexually Transmitted Infections Treatment Guidelines, 2021 — Centers for Disease Control and Prevention (CDC) (2021)
- Sexually Transmitted Infections Treatment Guidelines, 2021 (Full Report) — MMWR Recommendations and Reports (2021)
- Recommendation: Chlamydia and Gonorrhea: Screening — U.S. Preventive Services Task Force (USPSTF) (2021)
- Recommendation: Syphilis Infection in Nonpregnant Adolescents and Adults: Screening — U.S. Preventive Services Task Force (USPSTF) (2022)
- Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement — JAMA (2019)
- Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening — U.S. Preventive Services Task Force (USPSTF) (2020)
- Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systematic Review and Meta-Analysis — PLoS One (2015)
- Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program — Journal of Clinical Microbiology (2009)
- Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women — Journal of Clinical Microbiology (2018)
- Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians — Sexually Transmitted Infections (2010)
- Evaluating the sensitivity and specificity of dried blood spots for serological testing of HIV, syphilis, hepatitis B and C Elecsys assays on the Roche Cobas system — Pathology (2023)
- Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis — BMC Clinical Pathology (2014)
- New FDA Information on OraQuick In-Home HIV Test — HIV.gov (U.S. Department of Health and Human Services) (2020)
- Increasing Access to HIV Testing Through Direct-to-Consumer HIV Self-Test Distribution — United States, March 31, 2020–March 30, 2021 — MMWR (Morbidity and Mortality Weekly Report) (2021)
- WHO updates HIV testing guidance: more self-testing, integration, and prevention support — World Health Organization (WHO) (2024)
- FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting — National Cancer Institute (NCI) (2024)
- American Cancer Society Statement: FDA Approval of HPV Self-Collection for Cervical Cancer Screening — American Cancer Society (2024)
- Policies of US Companies Offering Direct-to-Consumer Laboratory Tests — JAMA Internal Medicine (2023)
- STD Testing: At Home Test Kits Explained (How It Works) — myLAB Box (Manufacturer) (2024)
- Frequently Asked Questions — myLAB Box (Manufacturer) (2024)
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.